Quanterix (QTRX) Capital Expenditures (2017 - 2026)
Quanterix (QTRX) posted Capital Expenditures of $87000.0 for Q1 2026, up 180.56% on a QoQ basis from -$108000.0 in Q4 2025, and down 93.07% year-over-year from $1.3 million in Q1 2025.
Quanterix (QTRX) Capital Expenditures (2017 - 2026) Analysis & Trends
Quanterix's Capital Expenditures history runs 10 years deep, the most recent figure standing at $87000.0 for Q1 2026.
- Quarterly Capital Expenditures fell 93.07% year-over-year to $87000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 million (down 146.6% YoY) and the FY2025 annual result came in at $121000.0, down 90.04% from the prior year.
- Capital Expenditures was $87000.0 for Q1 2026 at Quanterix, up from -$108000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $10.0 million in Q3 2022 and bottomed at -$1.8 million in Q3 2025.
- A 5-year average of $791529.4 and a median of $87000.0 in 2026 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures surged 159600.0% — and 2024, when it plunged 440.0%.
- Quanterix's Capital Expenditures stood at $1.6 million in 2022, then tumbled by 117.74% to -$283000.0 in 2023, then soared by 253.0% to $433000.0 in 2024, then sank by 124.94% to -$108000.0 in 2025, then soared by 180.56% to $87000.0 in 2026.
- Business Quant data shows QTRX's Capital Expenditures at $87000.0 in Q1 2026, -$108000.0 in Q4 2025, and -$1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | 87,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87,000.00 |
| Mar 31, 2026 | 87,000.00 |
| Dec 31, 2025 | -108,000.00 |
| Dec 31, 2025 | -108,000.00 |
| Sep 30, 2025 | -1.80 Mn |
| Sep 30, 2025 | -1.80 Mn |
| Jun 30, 2025 | 777,000.00 |
| Jun 30, 2025 | 777,000.00 |
| Mar 31, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 433,000.00 |
| Dec 31, 2024 | 433,000.00 |
| Sep 30, 2024 | -1.32 Mn |
| Sep 30, 2024 | -1.32 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 222,000.00 |
| Mar 31, 2024 | 222,000.00 |
| Dec 31, 2023 | -283,000.00 |
| Dec 31, 2023 | -283,000.00 |